PMID: 12417845Nov 6, 2002Paper

Atrial pacing for the prevention and termination of atrial fibrillation

The American Journal of Geriatric Cardiology
Irina Savelieva, A John Camm

Abstract

Atrial fibrillation (AF) affects about 2% of the general population and 8%-11% of those older than 65 years. The demand for effective therapeutic strategies for AF is anticipated to increase substantially as the proportion of the elderly population increases. Atrioventricular nodal ablation accompanied by permanent pacemaker implantation is an established option in elderly patients with intractable arrhythmia and poor ventricular rate control. However, it renders most patients pacemaker dependent and does not eliminate symptoms associated with loss of atrial transport or reduce the risk of stroke. The considerable limitations of rhythm or rate control strategies prompted interest in preventative atrial pacing, which may reduce the incidence of AF by either eliminating the triggers and/or by modifying the substrate of AF. Atrial or dual-chamber pacing has been proven to prevent or delay progression to permanent AF in elderly patients with sinus node dysfunction as compared with ventricular pacing. Patients with advanced atrial conduction delay may benefit from atrial resynchronization pacing. There may be additional benefits associated with the use of particular sites of pacing, specific pacing algorithms designed to target pote...Continue Reading

References

Oct 1, 1989·Cardiovascular Research·F SoltiA Juhász-Nagy
Jun 1, 1970·Circulation·M A Bennett, B L Pentecost
Apr 29, 1982·The New England Journal of Medicine·W B KannelP M McNamara
Sep 1, 1996·Circulation·K Reynen, W G Daniel
Oct 1, 1996·Circulation·E G DaoudF Morady
Sep 1, 1996·Journal of Cardiovascular Electrophysiology·T Satoh, D P Zipes
Apr 1, 1997·Circulation·R G TielemanH J Crijns
May 15, 1997·The New England Journal of Medicine·S R OmmenM S Stanton
Oct 10, 1997·Circulation·P PapageorgiouM E Josephson
Oct 23, 1997·Circulation·B M PsatyP M Rautaharju
Mar 25, 1998·Journal of Cardiovascular Electrophysiology·C TimmermansH J Wellens
May 30, 1998·Pacing and Clinical Electrophysiology : PACE·J SraM Akhtar
Sep 23, 1998·Pacing and Clinical Electrophysiology : PACE·S GarrigueJ Clémenty

❮ Previous
Next ❯

Citations

Mar 24, 2005·Progress in Cardiovascular Nursing·Carol Chen-Scarabelli
Sep 3, 2003·Journal of Cardiovascular Electrophysiology·Carsten W Israel, Stefan H Hohnloser
Jul 31, 2008·Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·W G de Voogt, N M van Hemel
Mar 31, 2015·The Cochrane Database of Systematic Reviews·Carmelo Lafuente-LafuenteJoël Belmin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.